RGD peptide GRGDNP

CAS No. 114681-65-1

RGD peptide GRGDNP ( )

Catalog No. M30440 CAS No. 114681-65-1

RGD peptide (GRGDNP) acts as an inhibitor of integrin-ligand interactions and can induce apoptosis in the absence of signals and integrin-mediated cell clustering.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 39 In Stock
5MG 65 In Stock
10MG 105 In Stock
25MG 215 In Stock
50MG 320 In Stock
100MG 474 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock

Biological Information

  • Product Name
    RGD peptide GRGDNP
  • Note
    Research use only, not for human use.
  • Brief Description
    RGD peptide (GRGDNP) acts as an inhibitor of integrin-ligand interactions and can induce apoptosis in the absence of signals and integrin-mediated cell clustering.
  • Description
    RGD peptide (GRGDNP) acts as an inhibitor of integrin-ligand interactions and can induce apoptosis in the absence of signals and integrin-mediated cell clustering.
  • Synonyms
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114681-65-1
  • Formula Weight
    614.6
  • Molecular Formula
    C23H38N10O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Ruoslahti, E., and ?brink, B. Common principles in cell adhesion Experimental Cell Research 227, 1-11 (1996).
molnova catalog
related products
  • ALG1001

    ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis.

  • ILK-IN-3

    ILK-IN-3 is an inhibitor of integrin linked kinase, and with antitumor activity.

  • BIO1211

    BIO1211 (BIO-1211) is a potent, highly specific integrin α4β1 (VLA-4) inhibitor with Kd/IC50 of 20 pM/4 nM for the activated form of α4β1.